Study into medication known as ‘King Kong’ of weight loss drugs throws fresh light on effects of longer-term use
People who use the drug Mounjaro are able to sustain weight loss for three years, data from a trial suggests.
Mounjaro, nicknamed the “King Kong” of weight loss drugs, contains tirzepatide and is self-administered in once-a-week injections.
More Stories
The latest twist in a Canadian medical mystery – podcast
World’s oldest fingerprint may be a clue that Neanderthals created art
Tech shares climb after strong Nvidia results despite warning over rise of Chinese rivals